1. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
  2. Potential Applications of NRF2 Modulators in Cancer Therapy
    Emiliano Panieri et al, 2020, Antioxidants CrossRef
  3. Geraniol and lupeol inhibit growth and promote apoptosis in human hepatocarcinoma cells through the MAPK signaling pathway
    Xionghu Shen et al, 2019, Journal of Cellular Biochemistry CrossRef
  4. Potential Applications of NRF2 Inhibitors in Cancer Therapy
    Emiliano Panieri et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  5. Resveratrol: biology, metabolism, and detrimental role on the tumor microenvironment of colorectal cancer
    Begum Dariya et al, 2023, Nutrition Reviews CrossRef
  6. Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
    Pavel Spirin et al, 2017, Oncotarget CrossRef
  7. Oridonin inhibits migration, invasion, adhesion and TGF‑β1‑induced epithelial‑mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK‑3β signaling pathway
    Chun‑Yu Li et al, 2017, Oncology Letters CrossRef
  8. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance
    Zahra Payandeh et al, 2020, Biochimie CrossRef
  9. Duality of bone morphogenetic proteins in cancer: A comprehensive analysis
    Tanu Sharma et al, 2022, Journal of Cellular Physiology CrossRef
  10. Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
    Rohitas Deshmukh et al, 2024, Current Pharmaceutical Biotechnology CrossRef
  11. Oridonin enhances TRAIL-induced apoptosis through GALNT14-mediated DR5 glycosylation
    Mi-Yeon Jeon et al, 2019, Biochimie CrossRef
  12. Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells
    Yu-Hua Zeng et al, 2017, Oncology Reports CrossRef
  13. Colorectal cancer and medicinal plants: Principle findings from recent studies
    Bachir Benarba et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  14. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
    Zerrin Sezgin-Bayindir et al, 2021, Antioxidants CrossRef
  15. Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression
    Bin-hua Zou et al, 2021, Acta Pharmacologica Sinica CrossRef
  16. Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities
    Weiyan Cheng et al, 2018, Mini-Reviews in Medicinal Chemistry CrossRef
  17. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
  18. Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis
    Siliang Wang et al, 2017, Oncotarget CrossRef
  19. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells
    Rong-Xing Liu et al, 2017, International Journal of Oncology CrossRef
  20. MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells
    Xuexiang Ying et al, 2017, Oncotarget CrossRef
  21. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling
    Rong-Xing Liu et al, 2018, International Journal of Oncology CrossRef
  22. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
    Ying Lu et al, 2018, Cell Death & Disease CrossRef
  23. Anti-proliferative Effect of a Novel Anti-oxidative Peptide in Hanwoo Beef on Human Colorectal Carcinoma Cells
    Hye-Jin Kim et al, 2018, Korean journal for food science of animal resources CrossRef